Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antiviral activity against Human adenovirus 7 infected in human HEp-2 cells assessed as reduction in viral growth incubated for 0.5 hrs followed by cell infection measured after 1 hr by crystal violet staining based assay relative to control
Assay data:3 Tested
SummaryPubMed Citation
Antiviral activity against Human adenovirus 2 infected in HEL cells assessed as reduction in virus-induced cytopathic effect by microscopic analysis
Assay data:6 Tested
Antiviral activity against Adenovirus 2 by cell infection assay
Assay data:13 Tested
Antiviral activity against Adenovirus 65089/Chicago infected in human A549 cells
Antiviral activity against Adenovirus type 5 VR-1523 infected in human Hep2 cells assessed as inhibition of virus-induced plaque formation/cytopathogenicity
Assay data:9 Tested
Antiviral activity against Adenovirus type 2 VR-1080 infected in human Hep2 cells assessed as inhibition of virus-induced plaque formation/cytopathogenicity
Antiviral activity against 10'-3 MOI Human adenovirus 2 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect
Assay data:1 Active, 1 Tested
SummaryCompounds, Active
Antiviral activity against 10'-2 MOI Human adenovirus 2 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect
Inhibitory activity of compound against Adenovirus type 2 (AD2) was evaluated in vitro; Inactive
In vitro antiviral activity against adeno virus using plaque reduction assay.
Assay data:1 Active, 7 Tested
SummaryCompounds, ActivePubMed Citation
Effective dose required for antiviral activity against adeno virus
Assay data:19 Tested
Antiviral activity against Human adenovirus 5 Adenoid 75 infected in A549 cells assessed as reduction in virus titer preincubated for 24 hrs followed by viral infection and measured after 72 hrs by microscopic analysis
Assay data:39 Tested
Antiviral activity against Human adenovirus 5 Adenoid 75 infected in A549 cells assessed as inhibition of viral adsorption at early stage of replication treated for 1 hr during viral infection followed by replacement with fresh medium and measured after 72 hrs by MTT assay
Assay data:42 Tested
Antiviral activity against Human adenovirus 5 infected in human A549 cells
Assay data:2 Tested
Antiviral activity against Adenovirus
Assay data:21 Tested
Antiviral activity against wild-type Human adenovirus 5 infected in human A549 cells assessed as inhibition of virus entry incubated for 48 hrs by fluorescence assay
Assay data:2 Active, 9 Tested
Antiviral activity against GFP-fused Human adenovirus 5 infected in 293beta5 cells assessed as inhibition of plaque formation incubated for 7 days by GFP reporter gene assay
Assay data:54 Active, 17 Activity ≤ 1 µM, 68 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Antiviral activity against Human adenovirus 2 infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by microscopic analysis
Assay data:2 Active, 17 Tested
Antiviral activity against Human adenovirus 5 infected in human A549 cells assessed as inhibition of viral entry after 48 hrs by GFP reporter gene based assay
Assay data:9 Active, 1 Activity ≤ 1 µM, 10 Tested
Antiviral activity against Human adenovirus 5 infected in 293beta5 cells assessed as inhibition of plaque formation incubated for 7 days by GFP reporter gene assay
Assay data:41 Active, 19 Activity ≤ 1 µM, 55 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on